Repository logo
Communities & Collections
All of DSpace
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Amani.H.I.Elgadal"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Thumbnail Image
    Item
    Tuberous sclerosis… the future
    (جامعة النيلين, 2012) Amani.H.I.Elgadal
    Tuberous sclerosis is genetic inherited disease as autosomal dominant .In the past it is thought to be a rare, but recently been found to be more common. Many people have mild symptoms; many remain asymptomatic for a long time before the diagnosis was made. The disease affects many organs: the brain, eyes, skin, kidneys, and in females the lungs as well as the heart may be involved, its progression is unpredictable. Many people think that: when seizures starts, couldn’t even with aggressive treatment, bother yourself waste time and recourses. Now tuberous sclerosis become a model genetic disease having new treatment opportunities like the mTOR inhibitors which has the potentiality to treat and/or improve symptoms and signs of the disease. Many researches had FDA approval, others in the process of approval which is the great hope. In this case I would like to refresh you about the disease, the future options regarding mainly neurological manifestations. The challenge in our situation is the availability feasibility, accessibility and sustainability.

DSpace software copyright © 2002-2025 LYRASIS

  • Privacy policy
  • End User Agreement
  • Send Feedback
Repository logo COAR Notify